top of page
Granules India enters the high growing peptide segment and CDMO business by acquiring Senn Chemicals AG.
Granules India announced the signing of the acquisition agreement regarding Senn Chemicals AG, a Swiss-based CDMO specialising in peptides
Feb 224 min read
Granules strengthens ADHD portfolio with FDA approval for Lisdexamfetamine Dimesylate Capsules
Granules India received the final approval from the US FDA for its ANDA for Lisdexamfetamine Dimesylate Capsules in strengths of 10-70 mg
Jan 302 min read
Granules’ net zero commitment validated and approved by Science Based Targets initiative
Granules received validation and approval from the Science Based Targets initiative (SBTi) for its near-term, long-term, and net-zero goals
Nov 27, 20242 min read
Mr. Ovais Sarmad joins as Advisor to Granules India Limited to guide sustainability and climate strategy
Mr. Sarmad will provide expert guidance on sustainability, climate policy, and environmental initiatives at Granules India Limited
Nov 18, 20242 min read
bottom of page